Cargando…

Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines

Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine upta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, Jung Yeon, Song, Joon Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312904/ https://www.ncbi.nlm.nih.gov/pubmed/30600652 http://dx.doi.org/10.3947/ic.2018.50.4.287

Ejemplares similares

Epidemiology and etiology of community-acquired pneumonia
por: Mandell, Lionel A.
Publicado: (2004)

Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia
por: De Schutter, Iris, et al.
Publicado: (2014)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
por: Shen, Ching-Fen, et al.
Publicado: (2020)

The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity
por: Sterky, Ellinor, et al.
Publicado: (2017)

Etiology of Community-Acquired Pneumonia
por: Apisarnthanarak, Anucha, et al.
Publicado: (2005)

Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults
por: Isturiz, Raul, et al.
Publicado: (2015)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Changes in the epidemiology and burden of community-acquired pneumonia in Korea
por: Yoon, Hyoung Kyu
Publicado: (2014)

COMMUNITY ACQUIRED PNEUMOCOCCAL PNEUMONIA IN NORTHWESTERN NIGERIA: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE AND OUTCOME
por: Iliyasu, Garba, et al.
Publicado: (2017)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China
por: Liang, Zhuoxin, et al.
Publicado: (2021)

Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
por: Negash, Abel Abera, et al.
Publicado: (2019)

Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan
por: Takeuchi, N., et al.
Publicado: (2020)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

1460. Community-Acquired Bacteremic Pneumonia in Post-pneumococcal Vaccination Era in a Pediatric Hospital
por: Gentile, Angela, et al.
Publicado: (2018)

Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience
por: Baldo, Vincenzo, et al.
Publicado: (2016)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
por: Endimiani, Andrea, et al.
Publicado: (2005)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
por: Principi, Nicola, et al.
Publicado: (2016)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study
por: Fonseca Lima, Eduardo Jorge da, et al.
Publicado: (2016)

Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
por: LeBlanc, Jason, et al.
Publicado: (2020)

1430. Evolving Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease
por: Yildirim, Inci, et al.
Publicado: (2018)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
por: Shen, Ching-Fen, et al.
Publicado: (2021)

Epidemiology of community acquired pneumonia
por: Manikam, Logan, et al.
Publicado: (2012)

Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016
por: von Mollendorf, Claire, et al.
Publicado: (2019)

Etiology of community-acquired and hospital-acquired pneumonia associated with COVID-19
por: Chemisova, O., et al.
Publicado: (2022)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines
por: Benfield, Thomas, et al.
Publicado: (2013)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

Diagnostic test for etiologic agents of community-acquired pneumonia
por: Bartlett, John G.
Publicado: (2004)

Epidemiology and surveillance implications of community-acquired pneumonia in children
por: Roh, Eui Jeong, et al.
Publicado: (2022)

Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine
por: Lima, Eduardo JF, et al.
Publicado: (2015)

Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia
por: Kim, Byunghyun, et al.
Publicado: (2018)

Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU
por: Belkhouja, Khairallah, et al.
Publicado: (2011)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study
por: Eklundh, Annika, et al.
Publicado: (2021)

Clinical, epidemiological, and etiological profile of inpatients with community-acquired pneumonia in a public hospital in the interior of Brazil
por: Bahlis, Laura Fuchs, et al.
Publicado: (2018)

Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)
por: Sicras-Mainar, Antoni, et al.
Publicado: (2012)

Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis
por: Heo, Jung Yeon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l1k2onle8aajaoh7okhm872k2i